全文获取类型
收费全文 | 2452篇 |
免费 | 140篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 200篇 |
妇产科学 | 57篇 |
基础医学 | 264篇 |
口腔科学 | 63篇 |
临床医学 | 313篇 |
内科学 | 556篇 |
皮肤病学 | 96篇 |
神经病学 | 81篇 |
特种医学 | 410篇 |
外国民族医学 | 1篇 |
外科学 | 105篇 |
综合类 | 51篇 |
一般理论 | 1篇 |
预防医学 | 198篇 |
眼科学 | 21篇 |
药学 | 107篇 |
2篇 | |
肿瘤学 | 141篇 |
出版年
2023年 | 5篇 |
2022年 | 8篇 |
2021年 | 19篇 |
2020年 | 19篇 |
2019年 | 25篇 |
2018年 | 41篇 |
2017年 | 30篇 |
2016年 | 36篇 |
2015年 | 48篇 |
2014年 | 59篇 |
2013年 | 73篇 |
2012年 | 54篇 |
2011年 | 61篇 |
2010年 | 93篇 |
2009年 | 96篇 |
2008年 | 67篇 |
2007年 | 102篇 |
2006年 | 66篇 |
2005年 | 71篇 |
2004年 | 37篇 |
2003年 | 34篇 |
2002年 | 41篇 |
2001年 | 55篇 |
2000年 | 39篇 |
1999年 | 54篇 |
1998年 | 132篇 |
1997年 | 160篇 |
1996年 | 134篇 |
1995年 | 114篇 |
1994年 | 114篇 |
1993年 | 101篇 |
1992年 | 42篇 |
1991年 | 53篇 |
1990年 | 51篇 |
1989年 | 66篇 |
1988年 | 58篇 |
1987年 | 56篇 |
1986年 | 63篇 |
1985年 | 60篇 |
1984年 | 34篇 |
1983年 | 25篇 |
1982年 | 25篇 |
1981年 | 29篇 |
1980年 | 26篇 |
1979年 | 6篇 |
1978年 | 13篇 |
1977年 | 21篇 |
1976年 | 25篇 |
1975年 | 16篇 |
1969年 | 2篇 |
排序方式: 共有2668条查询结果,搜索用时 0 毫秒
61.
King EM Kim HT Dang NT Michael E Drake L Needham C Haque R Bundy DA Webster JP 《Parasite immunology》2005,27(3):89-96
The role of the humoral immune system in human infection with Ascaris lumbricoides remains unclear. This study documents an epidemiological investigation in a highly endemic community in Vietnam, whereby serum antibody levels were assessed before treatment and after a 6-month reinfection period. These data were examined by correlation with infection status using an age-structured approach in an attempt to help shed light on the role of the humoral immune response. The first part of this study characterized levels of all serum antibody isotypes from the community in response to antigens of both adult and larval A. lumbricoides. Data were assessed in terms of their relation to host age and infection intensity with the aim to provide a broadly detailed account of immune responses to the parasite. In the second part, antibody responses to both life-stages of A. lumbricoides in serum samples collected before anthelmintic chemotherapy were analysed in relation to intensity of re-infection with the parasite 6 months following treatment. The results suggest that antibody responses may not confer protection from current infection or re-infection with A. lumbricoides and may not serve as reliable indicators of future infection intensity. Our results thereby lend support to the theory that immunity to A. lumbricoides may not be based on the humoral immune system. 相似文献
62.
63.
Molecular heterogeneity in acute leukemia lineage switch 总被引:1,自引:0,他引:1
Gagnon GA; Childs CC; LeMaistre A; Keating M; Cork A; Trujillo JM; Nellis K; Freireich E; Stass SA 《Blood》1989,74(6):2088-2095
Six cases of acute leukemia that underwent lineage switch from acute lymphocytic leukemia to acute myelogenous leukemia are reported. The mean age of the patients was 24 years, time to conversion was 36 months, and survival after conversion was only 3 months. Of the three cases which showed abnormal metaphases at both diagnosis and conversion, two (cases 2, 5) showed related cytogenetic abnormalities, and the third showed (case 3) independent chromosomal changes. Molecular analysis for immunoglobulin heavy chain and T-cell receptor beta chain genes showed that five of the six cases had rearrangement of at least one of these lymphoid associated genes at conversion to acute myelogenous leukemia. The single case (case 3) in which there were no lymphoid gene rearrangements at conversion was also the only case in which independent karyotypic abnormalities at diagnosis and conversion were demonstrated. Our findings suggest that lineage switch can represent either relapse of the original clone with heterogeneity at the molecular level or the emergence of a second new leukemic clone without molecular heterogeneity. 相似文献
64.
65.
S Wurtzer V Marechal JM Mouchel Y Maday R Teyssou E Richard JL Almayrac L Moulin 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2020,25(50)
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease (COVID-19). People infected with SARS-CoV-2 may exhibit no or mild non-specific symptoms; thus, they may contribute to silent circulation of the virus among humans. Since SARS-CoV-2 RNA can be detected in stool samples, monitoring SARS-CoV-2 RNA in waste water (WW) has been proposed as a complementary tool to investigate virus circulation in human populations.AimTo test if the quantification of SARS-CoV-2 genomes in WW correlates with the number of symptomatic or non-symptomatic carriers.MethodWe performed a time-course quantitative analysis of SARS-CoV-2 by RT-qPCR in raw WW samples collected from several major WW treatment plants in Greater Paris. The study period was 5 March to 23 April 2020, including the lockdown period in France (from 17 March).ResultsWe showed that the increase of genome units in raw WW accurately followed the increase of human COVID-19 cases observed at the regional level. Of note, the viral genome could be detected before the epidemic grew massively (around 8 March). Equally importantly, a marked decrease in the quantities of genome units was observed concomitantly with the reduction in the number of new COVID-19 cases, 29 days following the lockdown.ConclusionThis work suggests that a quantitative monitoring of SARS-CoV-2 genomes in WW could generate important additional information for improved monitoring of SARS-CoV-2 circulation at local or regional levels and emphasises the role of WW-based epidemiology. 相似文献
66.
Michael Moore Beth Stuart Samuel Coenen Chris C Butler Herman Goossens Theo JM Verheij Paul Little 《The British journal of general practice》2014,64(619):e75-e80
Background
Antibiotics are of limited overall clinical benefit for uncomplicated lower respiratory tract infection (LRTI) but there is uncertainty about their effectiveness for patients with features associated with higher levels of antibiotic prescribing.Aim
To estimate the benefits and harms of antibiotics for acute LRTI among those producing coloured sputum, smokers, those with fever or prior comorbidities, and longer duration of prior illness.Design and setting
Secondary analysis of a randomised controlled trial of antibiotic placebo for acute LRTI in primary care.Method
Two thousand and sixty-one adults with acute LRTI, where pneumonia was not suspected clinically, were given amoxicillin or matching placebo. The duration of symptoms, rated moderately bad or worse (primary outcome), symptom severity on days 2–4 (0–6 scale), and the development of new or worsening symptoms were analysed in pre-specified subgroups of interest. Evidence of differential treatment effectiveness was assessed in prespecified subgroups by interaction terms.Results
No subgroups were identified that were significantly more likely to benefit from antibiotics in terms of symptom duration or the development of new or worsening symptoms. Those with a history of significant comorbidities experienced a significantly greater reduction in symptom severity between days 2 and 4 (interaction term −0.28, P = 0.003; estimated effect of antibiotics among those with a past history −0.28 [95% confidence interval = −0.44 to −0.11], P = 0.001), equivalent to three people in 10 rating symptoms as a slight rather than a moderately bad problem. For subgroups not specified in advance antibiotics provided a modest reduction in symptom severity for non-smokers and for those with short prior illness duration (<7 days), and a modest reduction in symptom duration for those with short prior illness duration.Conclusion
There is no clear evidence of clinically meaningful benefit from antibiotics in the studied high-risk groups of patients presenting in general practice with uncomplicated LRTIs where prescribing is highest. Any possible benefit must be balanced against the side-effects and longer-term effects on antibiotic resistance. 相似文献67.
Rosanna Cuccurullo Silvia Govi Andrés JM Ferreri 《World journal of gastroenterology : WJG》2014,20(27):8993-8997
The treatment of primary gastric diffuse large B-cell lymphoma (DLBCL) has changed radically over the last 10–15 years, with the abandonment of routine gastrectomy in favor of more conservative therapies. Low-level evidence suggests that consolidation radiotherapy could be avoided in patients with limited-stage DLBCL of the stomach who achieve complete remission after rituximab-CHOP combination. Small, recent prospective trials suggest that selected patients with limited-stage Helicobacter pylori (H. pylori)-positive DLBCL of the stomach and favorable prognostic factors can be managed with antibiotics alone, with excellent disease control and cure rates, keeping chemo-radiotherapy for unresponsive patients. This recommendation should equally regard patients with mucosa-associated lymphoid tissue-related or de novo DLBCL. Future studies should be focused on the establishment of reliable variables able to distinguish the best candidates for exclusive treatment with H. pylori eradication from those who need for conventional chemo-immunotherapy. 相似文献
68.
69.